SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000934936-08-000023
Filing Date
2008-04-25
Accepted
2008-04-25 12:30:31
Documents
3
Period of Report
2008-06-05
Effectiveness Date
2008-04-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def-14a.htm DEF 14A 687745
2 GRAPHIC graphic.jpg GRAPHIC 8017
3 PROXY CARD proxycard.jpg GRAPHIC 129540
  Complete submission text file 0000934936-08-000023.txt   879296
Mailing Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006
Business Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006 4253730171
SCOLR Pharma, Inc. (Filer) CIK: 0000934936 (see all company filings)

IRS No.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31982 | Film No.: 08776721
SIC: 2835 In Vitro & In Vivo Diagnostic Substances